INTRODUCTIONHuman T‐lymphotropic virus‐1 (HTLV‐1) is an oncogenic human retrovirus that causes adult T‐cell leukemia/lymphoma (ATLL) and progressive HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV‐2, which is known to be endemic in African Pygmies and Native Americans as well as common in drug users, has not been clearly linked to any diseases.Worldwide, it is estimated that about 15 to 20 million people are infected with HTLV. The prevalence varies according to the geographic area, socio‐demographics and ethnic composition of the population, as well as specific risk groups, such as injecting drug users, sex workers, and people living with HIV (PLWH). In Brazil, it is estimated that 2.5 million people are infected with HTLV, with a frequency that varies according to geographic localization, but Brazil is undoubtedly considered an endemic area. The virus is transmitted from human to human through infected lymphocytes and may be acquired through sexual intercourse, blood transfusions, organ transplantations, contaminated needle reuse, and from mother‐to‐child transmission (MTCT) during pregnancy, at birth, and, more commonly, through breastfeeding.The studies evaluating the frequency of HTLV‐1 infection among pregnant women in Brazil have shown prevalence levels varying from 0.08% to 1.30%. However, investigation of HTLV during prenatal care is scarce, and little
Journal of Medical Virology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud